Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

PURPOSE: A proportion of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) do not achieve treatment goals or experience side effects on their current therapy. In such cases, switching patients to a new drug while discontinuing the first may...

Descripción completa

Detalles Bibliográficos
Autores principales: Gall, Henning, Vachiéry, Jean-Luc, Tanabe, Nobuhiro, Halank, Michael, Orozco-Levi, Mauricio, Mielniczuk, Lisa, Chang, MiKyung, Vogtländer, Kai, Grünig, Ekkehard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Pulmonary Hypertension
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942346/
https://www.ncbi.nlm.nih.gov/pubmed/29470642
http://dx.doi.org/10.1007/s00408-018-0100-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942346/
https://www.ncbi.nlm.nih.gov/pubmed/29470642
http://dx.doi.org/10.1007/s00408-018-0100-3

Ejemplares similares